甲磺酸奥希替尼
Tier A — Act nowOsimertinib Mesylate · all drugs expiring in 2031 →
Targets:EGFR、HER2、HER3、HER4、EGFR T790M、EGFR L858R、EGFR 19del
Brand:Tagrisso、泰瑞沙
Indications (approved):非小细胞肺癌
Regional status
Synthetic routes & intermediates4 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

| Code | CAS No. | Intermediate |
|---|---|---|
| OSIM-001 | 120-72-9Available | 1H-indole |
| OSIM-002 | 3934-20-1Available | 2,4-dichloropyrimidine |
| OSIM-003 | 945016-63-7Available | 3-(2-chloropyrimidin-4-yl)-1H-indole |
| OSIM-004 | 1032452-86-0Available | 3-(2-chloropyrimidin-4-yl)-1-methyl-1H-indole |
| OSIM-005 | 1075705-01-9Available | 4-fluoro-2-methoxy-5-nitroaniline |
| OSIM-006 | 1421372-94-2Available | N-(4-fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)pyrimidin-2-amine |
| OSIM-007 | 142-25-6Available | N1,N1,N2-trimethylethane-1,2-diamine |
| OSIM-008 | 1421372-67-9Available | N1-(2-(dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)-2-nitrobenzene-1,4-diamine |
| OSIM-009 | 1421372-66-8Available | N1-(2-(dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)benzene-1,2,4-triamine |
| OSIM-010 | 814-68-6Available | acryloyl chloride |
| OSIM-011 | 75-75-2Available | methanesulfonic acid |

| Code | CAS No. | Intermediate |
|---|---|---|
| OSIM-002 | 3934-20-1Available | 2,4-dichloropyrimidine |
| OSIM-004 | 1032452-86-0Available | 3-(2-chloropyrimidin-4-yl)-1-methyl-1H-indole |
| OSIM-005 | 1075705-01-9Available | 4-fluoro-2-methoxy-5-nitroaniline |
| OSIM-006 | 1421372-94-2Available | N-(4-fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)pyrimidin-2-amine |
| OSIM-007 | 142-25-6Available | N1,N1,N2-trimethylethane-1,2-diamine |
| OSIM-008 | 1421372-67-9Available | N1-(2-(dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)-2-nitrobenzene-1,4-diamine |
| OSIM-009 | 1421372-66-8Available | N1-(2-(dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)benzene-1,2,4-triamine |
| OSIM-011 | 75-75-2Available | methanesulfonic acid |
| OSIM-012 | 603-76-9Available | 1-methyl-1H-indole |
| OSIM-013 | 625-36-5Available | 3-chloropropanoyl chloride |
| OSIM-014 | 1421373-36-5Available | 3-chloro-N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)propanamide |

| Code | CAS No. | Intermediate |
|---|---|---|
| OSIM-004 | 1032452-86-0Available | 3-(2-chloropyrimidin-4-yl)-1-methyl-1H-indole |
| OSIM-005 | 1075705-01-9Available | 4-fluoro-2-methoxy-5-nitroaniline |
| OSIM-007 | 142-25-6Available | N1,N1,N2-trimethylethane-1,2-diamine |
| OSIM-010 | 814-68-6Available | acryloyl chloride |
| OSIM-015 | 1802924-13-5Available | tert-butyl (4-fluoro-2-methoxy-5-nitrophenyl)carbamate |
| OSIM-016 | 1802924-14-6Available | tert-butyl (4-((2-(dimethylamino)ethyl)(methyl)amino)-2-methoxy-5-nitrophenyl)carbamate |
| OSIM-017 | 1802924-15-7Available | tert-butyl (5-amino-4-((2-(dimethylamino)ethyl)(methyl)amino)-2-methoxyphenyl)carbamate |
| OSIM-018 | 1802924-16-8Available | N-(5-amino-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide |

| Code | CAS No. | Intermediate |
|---|---|---|
| OSIM-007 | 142-25-6Available | N1,N1,N2-trimethylethane-1,2-diamine |
| OSIM-010 | 814-68-6Available | acryloyl chloride |
| OSIM-018 | 1802924-16-8Available | N-(5-amino-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide |
| OSIM-019 | 29632-74-4Available | 2-fluoro-4-iodoaniline |
| OSIM-020 | 110-13-4Available | hexane-2,5-dione |
| OSIM-021 | 217314-30-2Available | 1-(2-fluoro-4-iodophenyl)-2,5-dimethyl-1H-pyrrole |
| OSIM-022 | 217314-31-3Available | 1-(2-fluoro-4-methoxyphenyl)-2,5-dimethyl-1H-pyrrole |
| OSIM-023 | 458-52-6Available | 2-fluoro-4-methoxyaniline |
| OSIM-024 | 1810048-26-0Available | N-(2-fluoro-4-methoxyphenyl)acrylamide |
| OSIM-025 | 1810048-27-1Available | N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide |
| OSIM-026 | 1810048-28-2Available | N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-nitrophenyl)acrylamide |
| OSIM-027 | 1810048-29-3Available | N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-5-guanidino-4-methoxyphenyl)acrylamide |
| OSIM-028 | 954421-16-0Available | (E)-3-(dimethylamino)-1-(1-methyl-1H-indol-3-yl)prop-2-en-1-one |
| OSIM-029 | 19012-02-3Available | 1-(1-methyl-1H-indol-3-yl)ethanone |
Frequently asked questions
What are the approved indications of Osimertinib Mesylate?
Approved indications include: 非小细胞肺癌.
When does the Osimertinib Mesylate patent expire?
Based on public sources, the Osimertinib Mesylate patent expires in 2031.
How many synthesis routes are recorded for Osimertinib Mesylate?
4 synthesis routes are recorded; the shortest is 5 steps with 190.5 mg total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Osimertinib Mesylate intermediates?
29 intermediate CAS of Osimertinib Mesylate are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.
How do I get a quote for Osimertinib Mesylate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24